Zavesca Report for Patients Like You : PatientsLikeMe

Filter by:

All
Start typing to see suggestions

patients

Home > Community Treatment Reports and Side Effects > Zavesca Treatment Report

You appear to have JavaScript disabled in your browser. PatientsLikeMe relies on JavaScript and Cookies to deliver the best possible experience to you. How do I enable JavaScript?

What is Zavesca?

Zavesca is a brand name for miglustat, a treatment for type 1 Gaucher Disease that cannot take enzyme replacement therapy. Zavesca prevents the formation of glycosphingolipids, which would normally accumulate in organs in Gaucher Disease.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose	# of patients	# of patients with evaluations Efficacy	Major	Moderate	Slight	None	Can’t tell
Degenerative neurological disorder	1	0

See all 3 patients currently taking Zavesca

Mouse over the table for more information

Reported Dosages

	100 mg daily	400 mg daily
	1	2

Reported Duration See details about how long patients take this treatment ▼ Reported Duration Hide details ▲

Currently Taking Zavesca

A bar graph

0-1 month	1-3 months	3-6 months	6 months-1year	1-2 years	2 years or more
0	0	0	1	0	2

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 24, 2012.